ArticleJACC. Basic to translational science2021

Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis.

Yuka Shiheido-Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.